The effects of impurities on crystallization of polymorphs of a drug substance AE1-923

Journal of Chemical Engineering of Japan

Volumn 37, Issue 10, 2004, Pages 1224-1231

  Okamoto, Masaki ^a   Hamano, Masaya ^b   Igarashi, Koichi ^a   Ooshima, Hiroshi ^a  

^a Osaka Prefecture University   (Japan)

^b ONO PHARMACEUTICAL CO   (Japan)

Author keywords

Crystal polymorphs; Drug substance; Impurity; Inhibition of transformation; Solvent mediated transformation

Indexed keywords

CONCENTRATION (PROCESS); CRYSTAL GROWTH; CRYSTALLIZATION; DISEASES; DRUG PRODUCTS; MATHEMATICAL TRANSFORMATIONS; NUCLEATION; RATE CONSTANTS; SOLVENTS;

CRYSTAL POLYMORPHS; POLLAKIURIA; POLYMORPH TRANSFORMATION; REACTION REAGENTS;

IMPURITIES;

CRYSTALLIZATION;

EID: 10844229476     PISSN: 00219592     EISSN: None     Source Type: Journal    
DOI: 10.1252/jcej.37.1224     Document Type: Article

References (10)

1. Audran, M., Y. Lasserre, J. Rambaud, B. Pauvert, G. Berge and L. Maury; "Comparative-Study of in vitro Dissolution and Bone Absorption of Sulfamethadine and One of Its Solvates," Pharm. Acta Helv., 63 343-346 (1988)
2. Davey, R. J., N. Blagden, G. D. Potts and R. Docherty; " Polymorphism in Molecular Crystals: Stabilization of a Metastable form by Conformational Mimicry," J. Am. Chem. Soc., 119, 1767-1772 (1997)
3. Domopoulou, A., A. Michaelides, S. Skoulika and D. Kovala-Demertzi; "Crystallization of an Unstable Molecular Compound Using a Tailor-Made Additive," J. Crystal Growth, 191, 166-168 (1998)
4. Kato, Y., Y. Okamoto, S. Nagasawa and T. Ueki; "Solubility of a New Polymorph of Phenobarbital Obtained by Crystallization in the Presence of Phenytoin," Chem. Pharm. Bull., 29, 3410-3413 (1981)
5. Kuroda, K., T. Yokoyama, T. Umeda, Y. Kita, A. Konishi and T. Kuroda; "Studies on Drug Nonequivalence VIII. Solubilities of Polymophs and Hydrate of Mercaptopurine," Yakugaku Zasshi, 99, 745-751 (1979)
6. Maruyama, S. and H. Ooshima; "Crystallization Behavior of Taltirelin Polymorphs in a Mixture of Water and Methanol," J. Crystal Growth 212, 239-245 (2000)
7. Maruyama, S., H. Ooshima and J. Kato; "Crystal Structures and Solvent-Mediated Transformation of Taltirelin Polymorphs," Chem. Eng. J., 75, 193-200 (1999)
8. Okamoto, M., M. Hamano and H. Ooshima; "Active Utilization of Solvent-Mediated Transformation for Exclusive Production of Metastable Polymorph Crystals of AE1-923," J. Chem. Eng. Japan, 37, 95-101 (2004)
9. Sudo, S., K. Sato and Y. Harano; "Growth and Solvent-Mediated Phase Transition of Cimetidine Polymorphic Forms A and B," J. Chem. Eng. Japan, 24, 628-632 (1991)
10. Lokoyama, T., T. Umeda, K. Kuroda, T. Kuroda and S. Asada; "Studies on Drug Nonequivalence X. Bioavailability of 6-Mercaptopurine Polymorphs," Chem. Pharm. Bull., 29, 194-199 (1981)